Paolo Rusconi, M.D.
- American Board of Pediatrics-Pediatric Cardiology
- Pediatric Cardiology
- Associate Professor of Clinical Pediatric
- Medical Director Pediatric Heart Transplant and Cardiac Failure
Heart failure in children and adults with congenital heart disease, cardiomyopathy, cardiac transplant, cardiac complications in children with renal disease, hypertension, preventive cardiology, sport clearance.
Role of biomarkers in heart failure, exercise in children with cardiac disease.
See Bio for more information
Super Doctors Award
1985 Diploma in Cardiology
University of Milan - Italy
University of Pavia
University of Pavia
Riley Children's Hospital
Jackson Memorial Hospital, University of Miami - Affiliated Medical Education Program
- Rusconi P., Gómez-Marín O., Rossique-González M., Redha M., Marín JR, Young ML, Wolff GS. Carvedilol in Children with Cardiomyopathy: 3 Years Experience in a Single Institution. J Heart Lung Transplant 2004;23:832–38
Dr. Rusconi graduated from medical school with the highest honor at the University of Pavia in 1982. After serving in the Italian army as a medical officer, he trained at the Brompton Hospital in London, as a research fellow in pediatric cardiology. In 1990, he moved to the USA where he completed a pediatric residency at the Indiana University in Indianapolis in 1993 and completed a fellowship in pediatric cardiology at the Miller School of Medicine University of Miami in 1996, where he remained as a Faculty. Dr. Rusconi is currently the Medical Director of the Pediatric Heart Transplant and Congestive Heart Failure Program.
Dr. Rusconi is an experienced physician in the area of pediatric heart failure secondary to cardiomyopathy, congenital heart disease, and renal failure and is the medical director of the pediatric heart failure and transplant program at the University of Miami Miller School of Medicine. Dr. Rusconi's area of research is the management of congestive heart failure in the pediatric population and adults with congenital heart disease. His experience with the use of beta-blockers, biomarkers and cardiac defibrillator is the management of heart failure in children has been published in leading scientific journals and the results of his research have been presented at national and international meetings.
Dr. Rusconi is Board Certified in Pediatrics (1993) and in Pediatric Cardiology (1998) and he is a member of the American College of Cardiology, American Heart Association and the International Society for Heart and Lung Transplant and he is a member of the Committee for the Guidelines for Management of Congestive Heart Failure in Children. Dr. Rusconi has been an active member of the NHLBI-Pediatric Cardiomyopathy Registry, which was established to describe the epidemiologic features and clinical course of selected cardiomyopathies and to promote the development of etiology-specific treatments. Dr. Rusconi is an active member of The Pediatric Heart Transplant Study (PHTS) a not-for-profit organization dedicated to the advancement of the science and treatment of children during listing for and following heart transplantation.